Nasdaq · Healthcare
PAYCHEX INC (PAYX)
As-reported financials and recent SEC filings for PAYCHEX INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.41B
Net income
$1.66B
Net margin
30.6%
Diluted EPS
$4.58
ROE
40.1%
P/E (TTM)
20.4×
Market cap
$35.52B
Debt / equity
1.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 | FY2024 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $5.41B | $5.13B | $4.91B | $4.55B | $2.74B |
| Gross profit | $3.87B | $3.65B | $3.45B | $3.20B | — |
| Operating income | $2.21B | $2.17B | $2.03B | $1.84B | $1.05B |
| Net income | $1.66B | $1.69B | $1.56B | $1.39B | $674.9M |
| Diluted EPS | $4.58 | $4.67 | $4.30 | $3.84 | $1.85 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-26
View on EDGAR →8-K2026-06-24
View on EDGAR →11-K2026-06-12
View on EDGAR →42026-06-02
View on EDGAR →42026-05-15
View on EDGAR →1442026-05-13
View on EDGAR →42026-05-12
View on EDGAR →1442026-05-08
View on EDGAR →Go deeper on PAYX
Search PAYCHEX INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.